Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | |||
Ventricular arrhythmia | 12.6% | x | x | x | x | x | |||||
Ventricular fibrillation | 0.2% | x | x | x | x | x | x | x | x | x | |
Anaphylactic shock | postmarketing | x | x | x | x | x | x | x | |||
Bronchospasm | postmarketing | x | x | x | x | x | x | x | x | ||
Rash | postmarketing | x | x | x | x | x | x | x | |||
Infusion site reaction | postmarketing | x | x | x | x | x | |||||
Angina pectoris | x | x | x | x | x | x | x | x | x | ||
Arrhythmia | x | x | x | x | x | x | x | ||||
Chest pain | x | x | x | x | x | x | x | x | x | ||
Patent ductus arteriosus | x | x | |||||||||
Headache | x | x | x | x | x | x | x | x | x | ||
Hypokalaemia | x | x | x | x | x | x | x | x | x | ||
Hypotension | x | x | x | x | x | x | x | x | x | ||
Thrombocytopenia | x | x | x | x | x | x | x | x | x | ||
Torsade de pointes | x | x | x | x | x | x | x | ||||
Tremor | x | x | x | x | x | x | x | x | x | ||
Ventricular tachycardia | x | x | |||||||||
Ventricular extrasystoles | x | x | x | x | x | x | x | x | x | ||
Liver function test abnormal | x | x | |||||||||
Arrhythmia supraventricular | x | x | x | x | x | x | x | x | x | ||
Non-sustained ventricular tachycardia | x | x | x | x | x | x | x | ||||
Sustained ventricular tachycardia | x | x | x | x | x | x | x |
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |